This article is in the news archive.
Do you work in spinal cord injury?
The Rick Hansen Institute (RHI) is in the process of developing a global commercialisation strategy and is looking to find companies and researchers in need of early-stage financing to help develop therapeutics, devices & diagnostics of relevance to those living with paralysis after a spinal cord injury. They are also looking to meet large corporates or potential VCs/Angel investors with a possible interest in the field with whom they might partner in the future.
What: The High Commission of Canada, in partnership with the Rick Hansen Institute, invites you to a Workshop & Networking Reception to discuss: "A Global Commercialisation Strategy for innovative therapies or technologies aimed at minimizing the effects of paralysis following Spinal Cord Injury"
Where: Canada House, Trafalgar Square, London, SW1Y 5BJ
When: Thursday 30 August 2012
3:00 - 5:30 PM Workshop
5:30 - 7:00 PM Reception
The Rick Hansen Institute has a mission to foster greater collaboration across the Spinal Cord Injury community and to accelerate progress towards a cure for paralysis after SCI. Through its core program areas (Translational Research, Best Practices implementation and the Rick Hansen SCI Registry) it has created a powerful network of researchers, clinicians and service providers who are working to improve the lives of those living with a spinal cord injury. http://www.rickhanseninstitute.org/en/
Bill Barrable, CEO of RHI, is visiting the UK later this month for the International Spinal Cord Society (ISCoS) Annual Meeting. Whilst in London, Bill is keen to meet UK researchers, clinicians, technology transfer organisations, companies and investors with an interest in spinal cord injury -- to discuss a global strategy for commercialisation that the RHI is in the early stages of developing.
The main objectives of the workshop are therefore to:
Through its commercialisation program, the RHI is looking to support emerging companies seeking Seed or Series A financing in order to commercialize an innovation (therapeutic, medical device or diagnostic) that has application to SCI and the associated secondary complications. The RHI is in the process of identifying "where the ideas are globally" and it is therefore keen to meet any such researchers, technology transfer organisations or companies in the UK and any local Angel and Venture Capital investors or corporate business development partners with an interest in the following areas:
Please RSVP by August 28th to Tina Hodges (Science & Innovation Assistant)
Tel: 020 7258 6364
Posted on 13/08/2012
Go to the news index page.